Financial Gravity Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3
Closed -$1.67K 1604
2024
Q1
$1.67K Sell
3
-5
-63% -$2.73K ﹤0.01% 700
2023
Q4
$4.34K Buy
+8
New +$3.76K ﹤0.01% 615
2021
Q3
$622K Buy
30
+8
+36% +$5.38K 0.29% 64
2021
Q2
$632K Buy
+22
New +$12.1K 0.23% 73
2020
Q4
$21K Buy
+42
New +$18.8K 0.02% 127
2019
Q4
$261K Sell
483
-132
-21% -$34.8K 0.18% 70
2019
Q3
$167K Sell
615
-173
-22% -$48.1K 0.14% 136
2019
Q2
$217K Sell
788
-125
-14% -$30.8K 0.18% 137
2019
Q1
$206K Buy
+913
New +$188K 0.17% 132
2018
Q3
$202K Buy
989
+72
+8% +$17.5K 0.21% 114
2018
Q2
$223K Sell
917
-70
-7% -$14.4K 0.21% 95
2018
Q1
$191K Buy
+987
New +$182K 0.2% 102

Other funds holding IDXX

Financial Gravity Asset Management's IDXX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 3 shares — an estimated $1.67K sold.

Financial Gravity Asset Management first reported a position in IDXX in Q1 2018 and held it in 12 quarters. The position peaked at $632K in Q2 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 3 Idexx Laboratories shares in Q2 2024, an estimated $1.67K.
  • Financial Gravity Asset Management first reported a position in Idexx Laboratories in Q1 2018 and held it in 12 quarters.
  • Financial Gravity Asset Management's Idexx Laboratories position peaked at $632K in Q2 2021.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.